Community Infections
Rapidly advancing the treatment of common and debilitating fungal infections
Dismissed. Stigmatized. Forgotten. We're changing that.
Our work in women’s health is putting a spotlight on vaginal yeast infections, which the scientific research community has all but ignored.
When it comes to infectious diseases, the area of women’s health is under-appreciated and very much under served. There is considerable misunderstanding or lack of awareness of how vaginal yeast infections can significantly affect women’s well-being, potentially resulting in fewer drug development companies focusing on this area. There is a clear underestimation of the unmet need, including patients that do not respond well to azole medications.
At SCYNEXIS, we are on a mission to address this unmet need and empower women with options to eliminate these insidious infections.
-
Vulvovaginal candidiasis (VVC)
VVC, commonly known as a vaginal yeast infection is the second most common vaginal infection affecting women of reproductive age in the United States.
Learn More -
Recurrent vulvovaginal candidiasis (RVVC)
RVVC infection, defined as three or more episodes of vulvovaginal candidiasis infection in one year, affects 5–8% of women during their childbearing years – millions of women worldwide.
Learn More
Our data on invasive infections
SCYNEXIS regularly presents key infectious disease study data at top medical meetings.
Learn More